title: [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
abstract: Human recombinant erythropoietin has been administered to 6 children with uremic anaemia in the course of end stage renal disease, treated with CAPD. The drug has been injected subcutaneously in the dose of 2,000 U twice a week, until hematocrit and hemoglobin values equivalent to 30% and 9-10 g/dL have been achieved. A decrease in cytotoxic antibodies titre has been noted during a 6-month follow-up. No serious adverse reactions have been seen.
authors.affiliation: Oddziału Dializoterapii i Transpalntacji Nerek Centrum Zdrowia Dziecka.
authors.forename: M
authors.initials: M
authors.lastname: Litwin
authors.forename: A
authors.initials: A
authors.lastname: Boguszewska-Baczkowska
authors.forename: A
authors.initials: A
authors.lastname: Jelonek
mesh_terms: D000293:Adolescent; D000740:Anemia / Q000209:etiology / Q000628:therapy*; D002648:Child; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011994:Recombinant Proteins; D014511:Uremia / Q000150:complications
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin
vernacular_title: Ludzka erytropoetyna rekombinowana w leczeniu niedokrwistości mocznicowej u dzieci dializowanych metoda ciagłej ambulatoryjnej dializy otrzewnowej.